NDC 63545-693

Ruthenium bromatum

Ruthenium Bromatum

Ruthenium bromatum is a Buccal; Oral; Sublingual Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Ruthenium Tribromide.

Product ID63545-693_5e808c4a-b3c6-0a05-e053-2991aa0a42a2
NDC63545-693
Product TypeHuman Otc Drug
Proprietary NameRuthenium bromatum
Generic NameRuthenium Bromatum
Dosage FormPellet
Route of AdministrationBUCCAL; ORAL; SUBLINGUAL
Marketing Start Date2017-11-21
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHahnemann Laboratories, Inc.
Substance NameRUTHENIUM TRIBROMIDE
Active Ingredient Strength30 [hp_C]/[hp_C]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 63545-693-01

240 [hp_C] in 1 VIAL, GLASS (63545-693-01)
Marketing Start Date2017-11-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63545-693-01 [63545069301]

Ruthenium bromatum PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-11-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
RUTHENIUM TRIBROMIDE30 [hp_C]/[hp_C]

OpenFDA Data

SPL SET ID:5e808c4a-b3c5-0a05-e053-2991aa0a42a2
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.